Sidebar

Intergraf welcomes the release of a study by our partner MLPS (Medical Leaflet = Patient Safety), a subgroup of the European Carton Manufacturers Association (ECMA) shedding light on the potential economic costs associated with the proposed use of Print on Demand (PoD) leaflets in the pharmaceutical legislation revision.

The findings of the semi-industrial trial come out of a study initiated by Avery Dennison and performed by The National Test center Circular Plastics assessing the releasability of filmic labels during rigid HDPE packaging recycling

Pharmaceutical products are developed and manufactured in a highly regulated environment. In addition to high hygiene stan-dards, medicines require a high degree of precision. The exact dosa-ge of active ingredients, the right mixture of ingredients and correct processing are crucial to ensure the efficacy and safety of the medi-cines.

For the 2021-2022 period, AWA’s Fiberboard Industry Consultancy Services (FICS) projected a moderate increase in the total global Medium Density Fiberboard (MDF) and particle board production capacity compared to the numbers from 2020-2021. The majority (58%) of the combined capacity consists of particle board.

Subcategories

Forum description to go here

Meet Our Sponsors

Latest Sponsor News

Articles Most Read

Latest News

Statistics

Articles View Hits
6959549

Who's Online

We have 57 guests and no members online